Stocks › Medical Care Facilities › STLN

Starling Oncology STLN

US equityMarket cap rank #3728Medical Care Facilities

$3.62 −$3.08 (-45.97%)

Market closed · Nov 6, 8:10 pm ET · Last extended-hours $3.63 +0.28%

Open$6.06

Prev close$6.70

Day range$3.35 – $6.43

Volume23.92M

Market cap$369.21M

P/E (TTM)–

Dividend yield–

Earnings

Quarter	Report date	Timing	Implied move	Actual move	Versus implied
2026/Q2	6 Aug 2026	After Market	±15.0%	+28.46%	Bigger than priced

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q2

By business line

Specialty Pharmacy$98.61M 61.1%
Patient Services$58.83M 36.5%
Clinical trials & other$3.85M 2.4%

Fundamentals

Full statements →

Latest reported quarter: Q2, ended Jun 2026

Revenue$161.28M+34.6% YoY

Operating profit-$4.62M+58.8% YoY

Net profit-$9.79M+42.4% YoY

Diluted EPS-$0.08+46.7% YoY

Free cash flow$11.03M+196.7% YoY

Operating cash flow$11.94M

Revenue, last 8 quarters

Net profit, last 8 quarters

Profitability & balance sheet

Gross margin15.7%

Operating margin-4.4%

Net margin-5.2%

Return on assets-18.1%

Current ratio1.36

Liabilities / assets114.0%

Cash & investments$41.09M

Total debt$97.25M

Net cash (debt)-$56.16M

Discussion

No comments yet — be the first to weigh in on STLN.